Pharma Intelligence is part of the Business Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Support the development and validation of your strategic plans and ensure commercial decisions are based on marketplace realities. Datamonitor Healthcare offers expert coverage of key diseases, treatments, companies, drugs, market access and market trends. Our primary research with physicians, payers, and KOLs (key opinion leaders) informs our treatment standards data and patient-based forecasts.
Discover unmet pharmaceutical needs. Effectively prioritize market opportunities. Deliver optimal returns. Datamonitor Healthcare’s in-depth expert data analysis and robust interactive data tools meet your needs and address your challenges in an ever-changing market.
How it helps
The breadth of coverage ensures you can assess revenue potential and identify competitive threats, market catalysts, and untapped new product development opportunities more holistically than ever before.
How it works
Content created by a global team of award-winning specialist analysts, and an easy-to-use interface that streamlines information gathering make Datamonitor Healthcare the go-to solution for the pharmaceutical and biotechnology industries.
It offers:
Assess revenue potential, competitive threats, market catalysts, and untapped product development opportunities with most up-to-date, comprehensive coverage of drugs, companies, epidemiology, diseases, strategy, and pricing and reimbursement trends.
Gauge the relative strength of upcoming drugs with our drug comparator tool. Identify untapped opportunities with our state-of-the art, interactive forecasting tool, event-driven forecasts updated within 48 hours, and patient-based sales forecasts from surveys of more than 200 physicians per indication.
Our acclaimed Ask-the-Analyst™ service puts you in direct contact with our global analyst team. Our comprehensive and timely market reports help you understand macro trends and synthesize key insights to make data actionable.
Receive accurate replies to your queries in minutes, not hours with 24/7 live customer support. Stay up-to-speed on the latest market developments with customizable email alerts that notify you of updates to the information most important to you.
Datamonitor Healthcare
19 Aug 2017
With the type two diabetes market undergoing unprecedented changes its important to know how this will shape the future dynamics of this competitive market. With our coverage you're able to analyse every aspect of this market.
Topic Diabetes
Datamonitor Healthcare
By Ljlal Syed, Mark Lansdell and David Abramson 19 Aug 2017
This report examines the extent to which order of market entry influences the prospects of achieving a satisfactory return on investment for companies developing branded generic
Topic Deal trends
Topic Drug approval
Datamonitor Healthcare
By Colin White, Robert Jeng & Jolene Lau 17 Aug 2017
This is an overview of the field of immuno-oncology and the various immuno-oncology classes. Immuno-oncology is one of the most promising and fastest growing areas of cancer research, as well
Topic immuno-oncology
Topic Cell and gene therapy
Datamonitor Healthcare
16 Aug 2017
Despite key markets pressures, the rheumatoid arthritis (RA) market is forecast to continue to grow over the next 10 years. Our RA coverage highlights where the opportunities remain, with a detailed look into the future of the RA treatment.
Topic Arthritis
Datamonitor Healthcare
By Jared Wolff 15 Aug 2017
Jared Wolff, Zach McLellan, Kevin Shannon and Jack Allen discuss current events in the healthcare space.
Topic Research
Datamonitor Healthcare
By Sultan Khan 10 Aug 2017
Phase II pamrevlumab IPF data alert Roche and Boehringer Ingelheim to major partnering opportunity.
Topic Biosimilars
Datamonitor Healthcare
05 Aug 2017
Big Pharma Outlook 2026 takes decade-long look at what’s in store for the future of Big Pharma.
Datamonitor Healthcare
28 Jul 2017
Jared Wolff, Zach McLellan, and newest member Kevin Shannon discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast.
Topic Cancer
Datamonitor Healthcare
18 Jul 2017
Jared Wolff, Jack Allen, and Zach McLellan discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast.
Topic Drug approval
Datamonitor Healthcare
12 Jul 2017
Datamonitor Healthcare estimates that Parkinson’s disease sales will grow substantially.
Datamonitor Healthcare
11 Jul 2017
Big Pharma is poised for growth because of strong launch portfolios, the availability of high-potential pipeline assets.
Datamonitor Healthcare
By Jared Wolff 06 Jul 2017
Jared Wolff, Jack Allen, and Zach McLellan discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast.
Topic Drug review
Datamonitor Healthcare
03 Jul 2017
Watch the Big Pharma 2026 Outlook webinar recording below
Rachel specializes in
+21 year(s) experience
Understand what’s happening in the market right now and what it means for the future of your business with news and insight from our team of journalists and analysts. Scrip is essential for anyone making commercial decisions in the pharmaceutical industry.
Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.
Get a window into what the leading players across the biopharma, medtech, and diagnostics industries are thinking, as well as important insight into what your competitors are doing. Build your strategy with In Vivo.
Looking for more products Product Finder
Request a Demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
How can we help you?
Our team is always happy to hear from you. Please call us at:
Report store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
